UniFAHS

BiotechnologySeedBangkok, Thailandunifahs.com

Latest round

Seed

Last raised

Jan 2024

Total raised

$1.4M

Investors

3

About UniFAHS

Based in Thailand and founded in 2020, UniFAHS is a biotechnology business that uses phage technology to tackle antimicrobial resistance while also ensuring food safety and sustainability. As of January 2024, Kitiya Vongkamjan is the Chief Executive Ofcier (CEO) of the company. UniFAHS uses phage technology for sustainable and safe food production, tackling global issues such as antimicrobial resistance (AMR). The company has a variety of phages that target important organisms connected to foodborne illnesses, such as Salmonella, E. coli, Listeria, and Vibrio. The company's focus extends to the animal industry, where they use phages to promote animal well-being. Furthermore, the company collaborates with partners including The University of Illinois, The University of Nottingham, Kasesart University, Newton Fund, Prince of Songkla University, and others.

Who invested in UniFAHS

3 investors across 1 round

See all investors in UniFAHS

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jan 4, 2024

    Amount

    $1.4M

    Investors

    Locked

Questions about UniFAHS

Who invested in UniFAHS?

UniFAHS has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has UniFAHS raised?

UniFAHS has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did UniFAHS last raise money?

UniFAHS's most recent round on record is a Seed, in Jan 2024.

What does UniFAHS do?

Based in Thailand and founded in 2020, UniFAHS is a biotechnology business that uses phage technology to tackle antimicrobial resistance while also ensuring food safety and sustainability.

Where is UniFAHS headquartered?

UniFAHS is headquartered in Bangkok, Thailand.

Which VCs invest in companies like UniFAHS?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at UniFAHS's stage. Their profiles are linked below.

Raising like UniFAHS? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.